Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Last revision Both sides next revision
home:diseases:cardiovascular [02.11.2019]
sallieq [Cardiovascular diseases]
home:diseases:cardiovascular [05.24.2019]
sallieq [More information]
Line 251: Line 251:
 //**Jen Hicks**, MarshallProtocol.com//</​blockquote>​ //**Jen Hicks**, MarshallProtocol.com//</​blockquote>​
 ===== More information ===== ===== More information =====
 +
 +Hyperuricaemia was associated with an unfavourable cardiovascular risk profile in HF patients. Treatment with low doses of allopurinol did not improve the prognosis of HF patients. ​ (({{pubmed>​long: ​   31119751}}))
  
   * [[http://​www.medicalnewstoday.com/​articles/​91894.php|Olmetec Is First Angiotensin Receptor Blocker (ARB) To Suggest Atherosclerosis Regression (in Hypertensives With Cardiovascular Risk)]]   * [[http://​www.medicalnewstoday.com/​articles/​91894.php|Olmetec Is First Angiotensin Receptor Blocker (ARB) To Suggest Atherosclerosis Regression (in Hypertensives With Cardiovascular Risk)]]
home/diseases/cardiovascular.txt · Last modified: 08.01.2019 by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.